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Abstract 
Spinal disease in dogs is commonly encountered in veterinary practice. Numerous 
diseases may cause similar clinical signs and presenting histories. The study objective was to 
use statistical models to identify combinations of discrete parameters from the patient 
signalment, history and neurological examination that could suggest the most likely diagnoses 
with statistical significance.  
 
A retrospective study of 500 dogs referred to the Queen Mother Hospital for Animals 
prior to June 2012 for the investigation of spinal disease was performed. Details regarding 
signalment, history, physical and neurological examinations, neuroanatomical localisation and 
imaging data were obtained. Univariate analyses of variables (breed, age, weight, onset, 
deterioration, pain, asymmetry, neuroanatomical localisation) were performed and variables 
retained in a multivariate logistic regression model if P<0.05. Leading diagnoses were 
intervertebral disc extrusion (IVDE, n=149), intervertebral disc protrusion (IVDP, n=149), 
ischaemic myelopathy (IM, n=48) and neoplasms (n=44).  
 
Multivariate logistic regression characterised IM and Acute Non-compressive Nucleus 
Pulposus Extrusions (ANNPE) as the only per-acute onset, non-progressive, non-painful and 
asymmetrical T3-L3 myelopathies. IVDE was most commonly characterised as acute onset, 
often deteriorating, painful and largely symmetrical T3-L3 myelopathy. This study suggests 
that most spinal diseases cause distinctive combinations of presenting clinical parameters 
(Signalment, Onset, Deterioration, Pain, Asymmetry, Neuroanatomical localisation). Taking 
particular account of these parameters may aid decision making in a clinical setting. 
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Abbreviations 
ANNPE: Acute non-compressive nucleus pulposus extrusion 
CKCS: Cavalier King Charles spaniels 
CM/SM: Chiari-like malformation/syringomyelia 
CSM: Cervical spondylomyelopathy 
DM: Degenerative myelopathy 
ECS: English Cocker Spaniels 
IM: Ischaemic myelopathy  
IVDD: Intervertebral disc disease  
IVDE: Intervertebral disc extrusion 
IVDP: Intervertebral disc protrusion 
DLSS: Degenerative lumbosacral stenosis  
MUA: Meningoencephalomyelitis of unknown aetiology 
SCS: Spinal cord segments 
SRMA: Steroid responsive meningitis and arteritis 
SBT: Staffordshire bull terriers 
XB: Cross breed 
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Introduction 
Spinal disease in dogs is commonly encountered in veterinary practice and 
encompasses over 40 diseases, many of which can produce similar histories and clinical signs 
(da Costa 2010b, Parent 2010). Determining which cases need rapid treatment for a favourable 
outcome usually requires diagnostic testing such as spinal imaging to be performed, however 
not all owners will be in a financial position to allow such investigations. Constructing an 
accurate as possible list of differential diagnoses, ranked in order of likelihood, allows rational 
decisions to be made not only in the formulation of an ideal diagnostic plan, but also in 
choosing reasonable empiric or symptomatic treatments. 
 
Using the neurological examination to determine where the lesion is along the neuraxis 
(neuroanatomical localisation) is a key step in investigating spinal disease (Parent 2010). Many 
diseases may however occur at any point along the length of the spinal cord, or if they have a 
predilection site, there may be sufficient overlap with possible locations of other diseases that 
further discrimination between differential diagnoses based on the neuroanatomical 
localisation alone is not possible. Individual spinal diseases may also be consistently associated 
with particular signalment, onset, deterioration and asymmetry of clinical signs, and evidence 
of apparent pain. For example ischaemic myelopathy (IM) and acute non-compressive nucleus 
pulposus extrusion (ANNPE) will cause per-acute onset, and often highly asymmetric clinical 
signs (De Risio and others 2009, De Risio and Platt 2010, Gandini and others 2003, McKee 
and others 2010). In contrast, intervertebral disc extrusion (IVDE) can often cause acute onset 
myelopathy with spinal hyperaesthesia, and is more prevalent in chondrodystrophic breeds 
(Brisson 2010). Taking consideration of these multiple, pertinent variables should allow a more 
refined list of differential diagnoses to be made. While experienced clinicians may intuitively 
use such a system in their clinical approach, it has yet to be subject to statistical evaluation. 
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Adopting a more systematic and evidence-based approach may make it possible to generate 
information and algorithms that are accessible to less-experienced clinicians and can be 
incorporated into clinical decision making on a daily basis (Schmidt 2007). The objective of 
this retrospective study was to use statistical analysis to identify factors from the history and 
neurological examination findings that were significantly associated with common spinal 
diseases in dogs presented for investigation at a referral hospital. An overall goal of this study 
was to provide clinicians with validated information with which to develop improved clinical 
reasoning when investigating spinal disease in dogs.  
 
Materials and Methods 
All records of dogs referred to the Royal Veterinary College Referral Hospital prior to 
June 2012 and investigated for a presumptive diagnosis of spinal disease were considered. 
Records were sequentially reviewed in a reverse chronological order until the required sample 
size of 500 dogs (derived from a modified sample size calculation) was achieved. Dogs 
included in this retrospective study required a complete neurological examination, full clinical 
records and MRI imaging. All included dogs had a full neurological examination and the 
neuroanatomical localisation determined by one of three board certified neurologists or four 
neurology residents under the supervision of board certified colleagues. MRI (1.5-Tesla 
Gyroscan NT, Philips Medical Systems) reviewed by a board certified radiologist was used to 
confirm lesion localisation and radiological diagnosis. MRI imaging was performed between 
three and forty seven hours after admission depending on the nature of the presenting condition. 
Guidelines on MRI characterisation of IM (Abramson and others 2005, De Risio and others 
2007), ANNPE (De Risio and others 2009, McKee and others 2010), neoplasms (Bagley 2010, 
Jull and others 2011, Palus and others 2012), degenerative lumbosacral stenosis (DLSS) (Meij 
and Bergknut 2010), Chiari-like malformation and syringomyelia (CM/SM) (Lu and others 
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2003, Rushbridge and others 2007) and intervertebral disc disease (IVDD) (Besalti and others 
2006, da Costa 2010a, Levine and others 2009) were used in making radiological diagnoses. 
Intervertebral disc disease was further classified as IVDE or intervertebral disc protrusion 
(IVDP) according to previously described methods (Besalti and others 2006). Surgery was 
subsequently performed in 95% of IVDE cases and 53% of IVDP cases at which time diagnosis 
was confirmed. Cases of osseous-associated cervical spondylomyelopathy and disc-associated 
cervical spondylomyelopathy were included under the single diagnosis Cervical 
Spondylomyelopathy (CSM) (De decker and others 2012, Delamaide Gasper and others 2014). 
Where required ancillary diagnostic tests including: CSF analysis, surgical biopsies, tests for 
infectious disease (bacterial culture/sensitivity, antibody titres and/or PCR for Toxoplamsa 
gondii, Neospora caninum or canine distemper virus) and genetic testing were used to confirm 
a diagnosis. Degenerative myelopathy (DM) is recognised as a post-mortem diagnosis. In this 
study all dogs with DM were presumptively diagnosed on the basis of a consistent clinical 
presentation and an A/A homozygous SOD-1 mutation (Awano and others 2009, Holder and 
others 2014, Zeng and others 2014). Of eight presumed DM cases three were subsequently 
available for post-mortem and all three dogs were diagnosed with DM at that time. 
 
Details regarding signalment, disease onset and deterioration, mentation, abnormalities 
in gait and posture, cranial nerve deficits, postural reaction deficits, spinal reflexes, spinal 
hyperaesthesia, nociception, asymmetry of neurological examination findings, neurologic 
grade (Modified Frankel Score (Van Wie and others 2013)) and treatment were obtained from 
clinical records. Clinical records were in the form of information provided by the referring 
veterinary practice, handwritten daily kennel sheets during hospitalisation at the Royal 
Veterinary College, and database records of diagnostic tests and imaging findings. Clinical 
deterioration was determined at the point of admission by an overall assessment of owner 
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perspectives, patient records provided by the referring veterinarian and information gained on 
initial neurological assessment following admission to the Royal Veterinary College. 
Determination of whether a condition was painful was primarily based on direct palpation and 
manipulation at the time of admission to the Royal Veterinary College but also took into 
account owners perspectives, patient records and in a small proportion cases analgesia 
administered prior to referral. Neurological signs were considered asymmetrical when there 
was an unequivocal difference in the neurological examination findings between the left and 
right side of the dog. Diagnoses with two or fewer cases, such as congenital abnormalities, 
vertebral malformations or trauma, were grouped into the category ‘Other’.  
 
All variables were treated as categorical. Onset (days to presentation) was classified as 
Peracute (<2 days), Acute (2-7 days) or Chronic (>7 days). Age was classified as Younger 
(<3years), Middle aged (3-9 years), Older  (>9 years). Size was classified as Smaller (<10kg), 
Medium size (10-30kg) or Larger (>30kg). A total of 39 animals without neurological deficits 
or with spinal pain only were excluded from the statistical analysis. Univariate analyses of 
potential explanatory variables for each condition were performed. Variables were considered 
for inclusion in multivariate logistic regression if P<0.30 and retained in the final model if 
P<0.05, based on the likelihood ratio test. Multivariate logistic regression was carried out using 
a Forced Entry Method (where all variables are entered into the equation in a single step) to 
examine associations between included variables with a significance level of P<0.05 
(Tabachnick & Fidell 2006). Results are presented with Odds Ratios (OR) and 95% confidence 
intervals (CI) for each condition versus the overall spinal disease population (Tabachnick & 
Fidell 2006). Following multivariate logistic regression for each disease variables retained in 
the final model (P<0.05) included: age/weight (Signalment), median time to presentation 
(Onset), deterioration of condition, pain on palpation or manipulation (Pain), asymmetry in 
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neurological deficits and neuroanatomical localisation. Non-normally distributed data was 
presented as median value with the range. Normally distributed data was presented as means 
and standard deviation (means ± SD). Computations were performed using SPSS (Statistical 
Package for the Social Sciences v. 21.0.1; SPSS Inc.). Information detailing the full output 
from multivariate logistic regression is included in Supplementary Table 1.  
 
Results 
Signalment 
Medical records and MR images of dogs with a presumptive diagnosis of spinal disease 
between January 2011 and June 2012 were included. Five hundred and seventy three dogs were 
initially considered with 51 excluded due to lack of MRI imaging and 22 excluded due to 
incomplete clinical records to leave a final sample population of 500 dogs. Mean age was 7.3 
± 3.2 years (Range: 21 days to 18 years) with mean body weight of 19.4 ± 13.2 kg (Range: 1.6 
kg-72.3 kg). One hundred and ninety one dogs were female (162 neutered, 29 entire) and 309 
were male (227 neutered, 82 entire). Twenty-six spinal diseases were included with IVDE (149 
cases), IVDP (95 cases), IM (48 cases) and neoplasms (44 cases) the leading diagnoses (Table 
1). Over 92% of cases were represented by the top ten spinal disease diagnoses (Table 1).  
There were 73 breeds with: cross-breeds (XB: 66), Cavalier King Charles spaniels 
(CKCS: 44), dachshunds (37), Staffordshire bull terriers (SBT: 25) and English cocker spaniels 
(ECS: 25) the leading breeds. Chondrodystrophic breeds accounted for 75.2% of IVDE. 
Cavalier King Charles spaniels accounted for 93.0% of CM/SM cases (P<0.0001) and 10.5% 
of IVDP cases.  
 
Cervical spondylomyelopathy, neoplasms and DLSS were more often seen in larger breed dogs 
while IVDE was more often associated with smaller breeds (Tables 1, 2). Neoplasms and IVDP 
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were associated with older dogs, whilst CSM was associated with younger dogs although this 
did not take into account specific diagnoses of Osseous-Associated CSM versus Disc-
Associated CSM (Tables 1, 2). Intrinsic myelopathies such as IM and ANNPE were associated 
with medium size or larger breeds (Tables 1, 2). 
 
Presentation 
Ischaemic myelopathy and ANNPE were per-acute conditions with median time to 
presentation (TTP) of one day (Figure 1, Table 1). Intervertebral disc extrusion presented 
acutely with a median TTP of two days. Inflammatory conditions such as Steroid Responsive 
Meningitis & Arteritis (SRMA) and Meningoencephalomyelitis of unknown aetiology (MUA) 
had a median TTP of approximately one week (Figure 1, Table 1). Neoplasms and IVDP both 
had a typically chronic but extremely varied time to deterioration with some cases presenting 
acutely whilst others had displayed clinical signs for many months (Figure 1, Table 1). 
Ischaemic myelopathy and ANNPE patients were clinically stable or improving in 92% of 
cases (Tables 1, 2). In contrast, the majority of dogs with DM, CM/SM, neoplasms, DLSS or 
inflammatory conditions had deteriorating clinical signs (Tables 1, 2). 
 
Neurological examination findings 
Over 92% of patients with spinal disease had overt neurological deficits on neurological 
examination. Exceptions included SRMA where no cases had neurological deficits and 
CM/SM where only 28% of cases had mild neurological deficits. All SRMA and CM/SM cases 
were noted to have spinal pain on palpation or manipulation. Meningoencephalomyelitis of 
unknown aetiology was the only spinal disease significantly associated with altered mentation 
(52% cases) and cranial nerve deficits (56%) (OR: 7.22, CI: 2.62-19.90. P=0.001) due to brain 
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involvement (Table 1). Cranial nerve abnormalities were also reported in 10 cases of neoplasia, 
due to the multifocal nature of the type of neoplasm involved (Table 1).   
 
Pain on palpation 
Spinal disease patients were frequently painful on palpation and manipulation with only 
IM (75% of cases) DM (88% of cases) and ANNPE (60% of cases) being generally non-painful 
(Tables 1, 2). Intervertebral disc extrusion, IM, ANNPE and neoplasms resulted in loss of deep 
pain perception in 5-6% of cases.  
 
Asymmetry 
Ischaemic myelopathy (81%), CSM (80%), ANNPE (79%) and neoplasms (70%) 
showed clear asymmetry of neurological deficit (Table 1). In contrast IVDE and IVDP only 
showed asymmetrical neurological examination findings in approximately 50% of cases (Table 
1).  
 
Neuroanatomical localisation 
There was 94% agreement between lesion localisation determined by neurological 
examination and location of the lesion identified on MRI. Neuroanatomical localisation varied 
significantly by spinal disease (Table 1). Between 67%-71% of IVDE, IM and ANNPE lesions 
occurred in T3-L3 spinal cord segments (SCS) (Table 1). There were an increased number of 
lesions at the T12-L2 intervertebral disc spaces with 58%, 41% and 52% of all IVDE, ANNPE 
and IM lesions occurring in this area respectively. Neoplasms had the most diverse localisation 
with lesions identified in all spinal cord segments and the brain (Table 1). MUA had multifocal 
lesions identified on MRI in 86% of cases, which invariably included at least one lesion 
detected in the brain. 
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Statistical modeling 
Statistically significant output of multivariate logistic regression for leading spinal diseases 
compared to the overall spinal disease population is shown in Table 2. Variables associated 
with particular spinal diseases are displayed as Odds Ratios (OR) with 95% confidence 
intervals to a significance level of P<0.05.  
 
Discussion 
The initial assessment and formulation of a diagnostic or empiric treatment plan for 
dogs presenting with signs of spinal disease can be challenging for clinicians. An accurate 
neuroanatomical localisation, as determined by a thorough neurological examination, is 
essential to establishing a list of likely or plausible differential diagnoses. However using other 
clinical information gained from the history and examination, in addition to the 
neuroanatomical localisation, to help define the problem more precisely will produce a more 
truncated and manageable list of differential diagnoses to work from. Using such a problem-
oriented approach has long been advocated in veterinary medicine as it provides a logical 
framework for clinical decision making (Lane 2008; May 2013). Although such an approach 
has recently been shown to be useful in dogs with brain disease it has never been investigated 
or validated in a large patient population of dogs with spinal disease (Armasu and others 2014). 
The objective of this preliminary study was to use statistical analysis to identify factors from 
the history, presentation and neurological examination that were associated with common 
spinal diseases, in order to improve clinical decision making with these cases.  
 
The spinal disease population in this study included a wide range of breeds (73), ages 
(21 days–18 years), sizes (1.6-72.3kg) and presenting clinical signs. 26 separate diagnoses were 
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reached, with the one of the ten most commonly occurring diseases being diagnosed in 92% of 
the dogs (Table 1). Although 92% of spinal disease cases presented with overt signs of 
neurological dysfunction a small group of dogs presented with spinal pain only. These included 
all dogs with SRMA and a large proportion of dogs (72%) with CM/SM. This absence of overt 
neurological dysfunction provides a useful initial point of classification in order to establish 
differential diagnoses in these dogs. By further considering factors from the history and 
presentation the confidence in a particular differential diagnosis can be further increased: 93% 
of CM/SM cases were CKCS (OR: 23.4, CI: 12.3-34.6, P=0.001) and 90% of SRMA cases 
were dogs under the age of two (OR: 13.1, CI: 7.3-20.3, P=0.001) (Driver and others 2013, 
Rusbridge and others 2006, Tipold and Schatzberg 2010). Due to the large number of diverse 
breeds included in the study, many with small sample sizes, it was not possible to effectively 
include breed as an independent variable in multivariate logistic regression analysis although 
this can be considered to be a focus of future work. 
 
A systematic consideration of signalment, onset, deterioration, pain, asymmetry and 
neuroanatomical localisation can be used to begin to effectively differentiate between those 
spinal diseases causing neurological dysfunction. IM and ANNPE were unique in being 
characterised as per-acute onset, non-progressive, largely non-painful and often highly 
asymmetric T3-L3 myelopathies that affected medium and larger breed dogs (Tables 1, 2, 
Figure 1) (De Risio and others 2009, De Risio and Platt 2010, Gandini and others 2003). This 
likely reflects the aetiology of the respective lesions, with fibrocartilaginous emboli obstructing 
the lumen of the lateralised spinal cord vasculature in IM and extruded nucleus pulposus 
causing spinal cord injury with little or no residual compression in ANNPE (De Risio and 
others 2009, De Risio and Platt, 2010, Gandini and others 2003). It is of note that 40% of dogs 
with ANNPE were considered to be painful. These dogs were typically referred within three to 
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six hours of onset and it possible they were still experiencing acute pain following the trauma 
of initial nucleus pulposus extrusion (De Risio and others 2009, McKee and others 2010). 
Seventy one percent of IM lesions and 67% of ANNPE lesions occurred in the T3-L3 spinal 
cord segments (Table 1). IM lesions were over 6-fold more likely to be associated with a T3-
L3 myelopathy (Tables 1, 2). There were no occurrences of IM in the C1-C5 spinal cord 
segments contrary to what has previously been reported (Tables 1, 2) (Abramson and others 
2005, De Risio and Platt 2010). IM and ANNPE were also more often associated with medium 
and larger sized dogs as previously described (Tables 1, 2) (De Risio and others 2009, De Risio 
and Platt 2010). Although the clinical presentation of IM and ANNPE has been described 
previously, the results of this study emphasise the value of recognising this characteristic set 
of clinical signs by demonstrating that it does not occur frequently in any other spinal disorder. 
Being able to include or exclude IM and ANNPE from a list of differential diagnoses is critical 
as both are non-surgical conditions. However advanced imaging may still be advisable as IM 
should be managed with early physiotherapy whilst ANNPE patients should ideally undergo 
an initial period of rest prior to active rehabilitation to prevent further disc extrusion (Abramson 
and others 2005, De Risio and others 2009, De Risio and Platt 2010, Gandini and others 2003, 
McKee and others 2010).    
 
IVDE was associated with middle-aged dogs of small or medium size (Tables 1, 2) that 
were often chondrodystrophic (OR: 16.1, CI: 9.1-28.3, P=0.002). IVDE cases were 2.2-fold 
more often associated with an acute presentation than other conditions and often had mildly 
deteriorating neurological signs (Figure 1, Tables 1, 2). The percentage of patients assessed as 
deteriorating may have been underestimated as the Modified Frankel Score is not suited to 
precise classification of neurological dysfunction in non-ambulatory dogs and many owners 
were unable to assess the deterioration of their dogs once they became non-ambulatory (Van 
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Wie and others 2013). In addition the rapid presentation and early surgical intervention in these 
dogs meant that the possibility of further deterioration was often avoided. IVDE cases were 
almost 7-fold more often associated with pain on neurological examination and over 40-fold 
more often associated with a T3-L3 myelopathy (Tables 1, 2) reflecting previous findings 
(Brisson 2010, Jeffery and others 2013, Kranenburg and others 2013). There was no 
statistically significant asymmetry in the neurological examination findings of IVDE cases 
(Table 2). In cases where asymmetry was noted, MRI findings agreed with lesion lateralization 
on clinical examination in only 57% of instances. This poor correlation likely reflects the 
bilateral nature of the spinal cord injury: the direct compression of the spinal cord by the 
extruded disc material, and the compression against the opposing vertebral lamina or pedicle 
(Besalti and others 2006, Brisson 2010, Jeffery and others 2013, Levine and others 2009). 
IVDE presents most predictably as an acute onset, deteriorating and painful T3-L3 myelopathy 
that is unlikely to show markedly asymmetric clinical signs (Tables 1, 2). In contrast, the 
common presenting characteristics of IVDP were suggestive of a more chronic onset, often 
stable but still painful myelopathy that affected medium sized middle aged or older dogs 
(Tables 1, 2). Whilst often localising to T3-L3 spinal cord segments, IVDP was 10-fold more 
often associated with C1-C5 SCS than other spinal diseases (Tables 1, 2). These findings 
correlate well with the previously described waxing and waning clinical signs and diverse 
localisation of chronic IVDP (Brisson 2010, Jeffery and others 2013). 
 
MUA presented as an acute onset condition, with the majority of patients showing signs 
of pain (Tables 1, 2). MUA was 38-fold more often associated with a multifocal 
neuroanatomical localisation with multiple SCS and the brain often affected (Tables 1, 2) 
(Tipold and Stein 2010). Neoplasms were more often associated with older and larger breed 
dogs and had a median TTP of 23 days with a maximum TTP of 187 days (Tables 1, 2). This 
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variation in TTP may reflect a diverse range of effects of individual neoplasms, with tumour 
type, location, histological grade/invasiveness, metastatic potential and the autoregulatory 
mechanisms allowing an individual to cope with a space occupying or progressively invasive 
neoplasm affecting the nervous system, which may vary widely (Bagley 2010, Park and others 
2012). Neoplasms were also associated with asymmetric neurological deficits (Table 2). DLSS 
and CSM were more often associated with larger breed dogs (Table 2) whilst CSM was 16-
fold more likely to be associated with younger dogs and have a chronic onset which was 
consistent with previous findings (da Costa 2010c, De Decker and others 2012, Gasper and 
others 2014). This study did not differentiate between osseous-associated CSM and disc-
associated CSM which are known to have characteristic age and breed predictions (da Costa 
2010c, De Decker and others 2012, Gasper and others 2014). It is of note that six out of 10 
cases were confirmed as osseous-associated CSM which may have contributed to the 
association of CSM with younger dogs.   
 
The goal of this study was to establish statistically significant parameters that could be 
used to improve clinical decision making in evaluating dogs with spinal disease. These 
preliminary data confirm that spinal diseases had statistically significant combinations of 
clinical parameters. The data also show that using as few as six variables (Signalment, Onset, 
Deterioration, Pain, Asymmetry, Neuroanatomical Localisation) systematically evaluated from 
the history and neurological examination can aid in generating a focused list of differential 
diagnoses (Figure 2). Used appropriately a shorter and more realistic list of differential 
diagnoses permits the clinician to institute more cost-effective, appropriate and timely 
diagnostic and treatment plans. In many cases this may involve the decision on if and when to 
refer a case for specialist investigation and treatment, or whether empiric therapy based on 
clinical suspicion is likely to succeed in cases where further investigations are not possible or 
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permitted. Narrowing the diagnostic possibilities using rigorously applied clinical reasoning 
may also improve the accuracy of prognostications where a definitive diagnosis cannot be 
made. 
 
The clinical presentations of some conditions are highly consistent, such as ANNPE, IM, 
IVDE, whilst others are less precisely characterised. As with all statistical approaches the 
methods employed in this analysis have some limitations. The 500 cases were selected 
sequentially as they presented to our clinic meaning that some conditions were represented in 
greater numbers than others. By default this means that the number of cases (dogs with the 
spinal disease of interest) and the associated number of controls (dogs without that disease) 
varies by diagnosis. Although this variance is automatically accounted for in the logistic 
regression model it inherently means that conditions with fewer cases lack the statistical power 
of other diseases. The statistical significance of presenting characteristics for some diseases 
could be improved with increased sample sizes, and although it would have been possible to 
artificially select patients for each diagnosis we felt the current analytical approach more 
accurately reflected our presenting population, and therefore the conclusions and statistical 
inferences were more relevant. It is also evident that the analysis is somewhat dependent on 
the owner’s recollection of their pet’s condition and that the presentation of the cases may have 
been influenced by previous treatment. Future work will involve increasing the case numbers 
for each spinal disease to further refine and improve the statistical associations for each disease. 
It is recognised that this analysis was carried out on a referral population, which will inherently 
bias cases towards the more severe end of the spectrum where advanced imaging or surgical 
intervention are thought necessary. There are no data or publications currently available with 
which to compare the presentation of spinal diseases in first opinion practice in the UK 
although work is ongoing using the RVC VetCompass database to address this issue. It is clear 
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that the management of complex spinal disease cases cannot be reduced to a simple algorithm, 
nor is that the intention of this study. However, attempts to develop a statistically supported 
evidence base from which to determine clinical decisions and diagnostic approach should be 
considered both valid and necessary. Use of such knowledge could improve the timeliness and 
accuracy of diagnosis in dogs presenting with signs of spinal disease. 
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Table 1: Summary of presentation and neurological examination findings by spinal disease 
 
   Signalment Presentation Neurological deficits Neuroanatomical localisation 
 
n %  Age 
(years, median 
and range) 
Weight 
(kg, median and 
range) 
Median time to 
presentation 
(days, range) 
Deteriorating Pain on 
palpation or 
manipulation 
Asymmetric 
deficits 
Multifocal C1-C5 C6-T2 T3-L3 L4-
S3 
Intervertebral Disc Extrusion 
(IVDE) 
149 29.8 7.0  
(2.6-16.4) 
11.1  
(3.6-52.0) 
2.0  
(1.0-39.0) 
55% 87% 48% 1% 15% 6% 71% 6% 
Intervertebral Disc Protrusion 
(IVDP) 
95 19.0 8.5  
(1.4-16.3) 
15.3  
(4.4-49.0) 
22.0  
(3.0-190.0) 
44% 84% 52% 6% 29% 21% 37% 6% 
Ischaemic Myelopathy (IM) 
48 9.6 6.3  
(1.8-18.1) 
22.0  
(3.7-72.3) 
1.0  
(1.0-10.0) 
8% 25% 81% 0% 0% 17% 71% 12% 
Neoplasm 
44 8.8 9.1  
(3.1-15.1) 
23.3  
(7.0-63.0) 
22.5  
(2.0-181.0) 
59% 75% 70% 20% 7% 25% 30% 18% 
Chiari-Like malformation / 
Syringomyelia (CM/SM) 
29 5.8 5.1  
(1.0-10.1) 
10.1  
(6.5-15.4) 
44.0  
(1.0-186.0) 
76% 97% 14% 59%* 38% 0% 3% 0% 
Meningoencephalomyelitis 
Unknown Aetiology (MUA) 
29 5.8 5.7  
(0.9-15.2) 
9.8  
(1.6-36.7) 
7.0  
(2.0-62.0) 
59% 86% 45% 86% 3% 3% 3% 3% 
Acute Non-Compressive Nucleus 
Pulposus Extrusion (ANNPE) 
24 4.8 8.5  
(1.4-13.2) 
23.4  
(2.6-52.0) 
1.0  
(1.0-8.0) 
8% 40% 79% 0% 12% 21% 67% 0% 
Degenerative Lumbosacral 
Stenosis (DLSS) 
14 2.8 8.2  
(2.9-14.3) 
31.5  
(12.1-51.0) 
14.5  
(4.0-169.0) 
64% 100% 64% N/A N/A N/A 7% 93% 
Cervical Spondylomyelopathy 
(CSM) 
10 2.0 6.8  
(2.4-10.5) 
41.2  
(12.1-72.0) 
16.0  
(4.0-131.0) 
50% 80% 80% 0% 50% 50% N/A N/A 
Steroid Responsive Meningitis & 
Arteritis (SRMA) 
9 1.8 1.7  
(1.2-4.9) 
11.1  
(2.0-14.7) 
6.0  
(3.0-21.0) 
56% 100% 0% 56%a 44%a 0% 0% 0% 
Subarachnoid Diverticulum 
9 1.8 6.1  
(1.8-9.4) 
31.4  
(5.8-57.0) 
30.0 (10.0-123.0) 44% 67% 22% 11% 22% 44% 22% 0% 
Bacterial / Protozoal 
8 1.6 6.7  
(2.2-11.1) 
24.8  
(11.5-45.0) 
19.0 (2.0-99.0) 62% 100% 62% 0% 0% 0% 50% 50% 
Degenerative Myelopathy (DM) 
8 1.6 9.6  
(8.1-13.3) 
34.6  
(21.6-42.7) 
90.5 (24.0-181.0) 100% 12% 50% 12% 0% 0% 62% 25% 
Other 24 4.8%            
*72% of dogs with CM/SM presented with only pain and no neurological deficits.  28% of dogs with CM/SM had both pain and neurological deficits 
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Table 2: Multivariate logistical regression analysis of presentation and neurological examination characteristics of leading spinal diseases with 10 or more cases 
 
 n Signalment (age, size) 
Onset (days to 
presentation) 
Deteriorating 
Pain on palpation or 
manipulation 
Asymmetric deficits 
Neuroanatomical 
localisation 
Intervertebral Disc Extrusion 
(IVDE) 
147 
Middle aged 
3.4 (1.7-6.9) 
P = 0.001 
Smaller 
4.7 (1.9-10.1) 
P = 0.002 
 
Medium size 
2.4 (1.1-5.4) 
P = 0.03 
Acute 
2.2 (1.4-4.1) 
P = 0.04 
Deteriorating 
2.4 (1.3-4.5) 
P = 0.005 
 
Painful 
6.9 (3.4-14.1) 
P = 0.001 
Rarely asymmetric 
0.5 (0.3-0.9) 
P = 0.01 
 
T3-L3 
42.6 (8.7-207.7) 
P = 0.0001 
 
C1-C5 
17.2 (3.3-90.3) 
P = 0.001 
Intervertebral Disc Protrusion 
(IVDP) 
92 
Middle aged 
4.2 (0.9-19.4) 
P = 0.04 
 
Older 
8.8 (1.8-43.2) 
P = 0.007 
Medium size 
4.4 (2.1-10.4)  
P = 0.004 
Chronic 
74.6 (17.1-125.3) 
P = 0.001 
Often stable 
0.5 (0.3-0.9) 
P = 0.016 
Painful 
1.7 (0.9-3.4) 
P = 0.05 
- 
C1-C5 
10.1 (3.5-29.5) 
P = 0.001 
 
T3-L3 
9.4 (3.1-28.5) 
P = 0.002 
Ischaemic Myelopathy (IM) 48 - 
Medium size 
2.5 (1.1-5.6) 
P = 0.02 
 
Larger  
2.3 (1.1-5.3) 
P = 0.03 
Peracute 
2.6 (1.9-8.5) 
P = 0.04 
Stable or improving 
0.18 (0.06-0.6) 
P = 0.005 
Non-painful 
0.12 (0.1-0.3) 
P = 0.001 
Asymmetric 
2.9 (2.0-7.1) 
P = 0.02 
T3-L3 
6.3 (3.9-9.1)  
P = 0.005 
Neoplasm 44 
Older 
2.2 (1.8-5.6) 
P = 0.017 
Larger 
3.9 (1.7-8.7) 
P = 0.001 
Chronic 
8.3 (2.4-19.4) 
P = 0.001 
Deteriorating 
1.4 (1.0-3.9) 
P = 0.04 
- 
Asymmetric 
2.7 (1.3-5.6) 
P = 0.006 
- 
Meningoencephalomyelitis 
Unknown Aetiology (MUA) 
29 - - 
Acute 
7.1 (1.2-21.8) 
P = 0.03 
- - - 
Multifocal 
38.7 (4.6-126.8) 
P = 0.01 
Acute Non-Compressive 
Nucleus Pulposus Extrusion 
(ANNPE) 
24 - 
Medium size 
3.8 (1.0-14.7) 
P = 0.01 
 
Larger 
2.0 (0.9-6.5) 
P = 0.03 
Peracute 
2.0 (1.1-3.6)  
P = 0.04 
Stable or improving 
0.4 (0.3-1.1) 
P = 0.04 
- 
Asymmetric 
2.2 (1.1-4.7) 
P = 0.04 
- 
Degenerative Lumbosacral 
Stenosis (DLSS) 
14 - 
Larger 
12.3 (1.6-96.1) 
P = 0.02 
- - - - - 
Cervical Spondylomyelopathy 
(CSM) 
10 
Younger 
16.3 (3.6-36.1) 
P = 0.02 
Larger 
6.7 (1.0-55.2) 
P = 0.04 
Chronic 
10.4 (1.1-100.8) 
P = 0.04 
- - - - 
Where statistically significant (P≤0.05) data presented include Odds Ratios with 95% confidence intervals (CI) indicated in parentheses. Characteristics with no 
statistically significant bias are indicated with ‘-’ 
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Figure legends 
 
Figure 1: Boxplot of time to presentation (days) for leading spinal diseases 
 
 
 
The bottom and top lines of the box represent the first and third quartiles, the line inside the box represents the median, error bars represent the 
95% confidence intervals and circles outside the box represent outliers.   
Bact/Prot: bacterial or protozoal infections e.g. diskospondylitis, CM/SM: Chiari-like malformation/syringomyelia, CSM: Cervical 
spondylomyelopathy, DM: Degenerative myelopathy, ANNPE: Acute non-compressive nucleus pulposus extrusion, IM: Ischaemic myelopathy, 
IVDD: Intervertebral disc disease, IVDE: Intervertebral disc extrusion, IVDP:  Intervertebral disc protrusion, DLSS: Degenerative lumbosacral 
stenosis, MUA: Meningoencephalomyelitis of unknown aetiology, SRMA: Steroid responsive meningitis and arteritis 
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Figure 2: Schematic of statistically significant associations with common spinal diseases. ANNPE, acute 
non-compressive nucleus pulposus extrusion; CM/SM, Chiari-like malformation/syringomyelia; CSM, 
cervical spondylomyelopathy; IM, ischaemic myelopathy; IVDE, intervertebral disc extrusion; IVDP, 
intervertebral disc protrusion; SRMA, steroid-responsive meningitis and arteritis 
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Supplementary Table 1: Multivariate logistical regression analysis of presentation and neurological 
examination characteristics of leading spinal diseases with 10 or more cases.  
Onset (days to presentation) was classified as Peracute (<2 days), Acute (2-7 days) or Chronic (>7 days). Age 
was classified as Younger (<3years), Middle aged (3-9 years), Older  (>9 years). Size was classified as Smaller 
(<10kg), Medium size (10-30kg) or Larger (>30kg). Variables where no data are recorded are indicated by 
N/A (not applicable). Data with statistical significance of P ≤0.05 are indicated in bold.  
 
Spinal disease n Characteristic Variable Odds ratio 
95% Confidence 
interval 
P Value 
Intervertebral Disc Extrusion (IVDE) 147 
Signalment (age, size) 
 
 
 
 
 
 
 
Onset (days to presentation) 
 
 
 
Deteriorating 
 
Pain  
 
Asymmetry 
 
Neuroanatomical localisation 
Smaller 
Medium size 
Larger 
 
Younger 
Middle aged 
Older 
 
Peracute 
Acute 
Chronic 
 
Deteriorating 
 
Painful 
 
Asymmetrical 
 
Multifocal 
C1-C5 
C6-T2 
T3-L3 
L4-S3 
4.7 
2.4 
1.1 
 
0.8 
3.4  
1.1 
 
1.6 
2.2 
0.02 
 
2.4 
 
6.9 
 
0.5 
 
0.9 
17.2 
6.3 
42.6 
7.6 
1.9-10.1 
1.1-5.4 
0.9-1.9 
 
0.2-1.1 
1.7-6.9 
0.9-2.2 
 
1.1-2.3 
1.4-4.1 
0.01-0.05 
 
1.3-4.5 
 
3.4-14.1 
 
0.3-0.9 
 
0.4-2.0 
3.3-90.3 
1.2-32.6 
8.7-207.7 
1.4-42.1 
0.002 
0.03 
0.64 
 
0.11 
0.001 
0.24 
 
0.14 
0.04 
0.001 
 
0.005 
 
0.001 
 
0.01 
 
0.53 
0.001 
0.11 
0.0001 
0.07 
Intervertebral Disc Protrusion 
(IVDP) 
92 
Signalment (age, size) 
 
 
 
 
 
 
 
Onset (days to presentation) 
 
 
 
Deteriorating 
 
Pain  
 
Asymmetry 
 
Neuroanatomical localisation 
Smaller 
Medium size 
Larger 
 
Younger 
Middle aged 
Older 
 
Peracute 
Acute 
Chronic 
 
Deteriorating 
 
Painful 
 
Asymmetrical 
 
Multifocal 
C1-C5 
C6-T2 
T3-L3 
L4-S3 
1.8 
4.4 
0.6 
 
0.8 
4.2 
8.8 
 
0.9 
6.9 
74.6 
 
0.5 
 
1.7 
 
0.8 
 
1.0 
10.1 
3.2 
9.4 
2.1 
1.1-3.6 
2.1-10.4 
0.3-1.3 
 
0.1-1.3 
0.9-19.4 
1.8-43.2 
 
0.6-2.1 
2.2-45.1 
17.1-125.3 
 
0.3-0.9 
 
0.9-3.4 
 
0.4-1.4 
 
0.6-2.3 
3.5-29.5 
2.1-16.9 
3.1-28.5 
0.5-7.9 
0.30 
0.004 
0.16 
 
0.31 
0.04 
0.007 
 
0.41 
0.10 
0.001 
 
0.016 
 
0.05 
 
0.41 
 
0.64 
0.001 
0.13 
0.002 
0.23 
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Ischaemic Myelopathy (IM) 48 
Signalment (age, size) 
 
 
 
 
 
 
 
Onset (days to presentation) 
 
 
 
Deteriorating 
 
Pain  
 
Asymmetry 
 
Neuroanatomical localisation 
Smaller 
Medium size 
Larger 
 
Younger 
Middle aged 
Older 
 
Peracute 
Acute 
Chronic 
 
Deteriorating 
 
Painful 
 
Asymmetrical 
 
Multifocal 
C1-C5 
C6-T2 
T3-L3 
L4-S3 
1.2 
2.5 
2.3 
 
0.5 
1.1 
0.7 
 
2.6 
0.4 
0.1 
 
0.18 
 
0.12 
 
2.9 
 
N/A 
N/A 
0.7 
6.3 
0.8 
0.5-3.2 
1.1-5.6 
1.1-5.3 
 
0.1-2.1 
0.2-6.3 
0.1-4.7 
 
1.9-8.5 
0.2-1.1 
0.0-0.32 
 
0.06-0.6 
 
0.1-0.3 
 
2.0-7.1 
 
N/A 
N/A 
0.1-3.2 
3.9-9.1 
0.2-2.8 
0.71 
0.02 
0.03 
 
0.43 
0.95 
0.70 
 
0.04 
0.16 
0.05 
 
0.005 
 
0.001 
 
0.02 
 
N/A 
N/A 
0.61 
0.005 
0.78 
Neoplasm 44 
Signalment (age, size) 
 
 
 
 
 
 
 
Onset (days to presentation) 
 
 
 
Deteriorating 
 
Pain  
 
Asymmetry 
 
Neuroanatomical localisation 
Smaller 
Medium size 
Larger 
 
Younger 
Middle aged 
Older 
 
Peracute 
Acute 
Chronic 
 
Deteriorating 
 
Painful 
 
Asymmetrical 
 
Multifocal 
C1-C5 
C6-T2 
T3-L3 
L4-S3 
0.9 
4.1 
3.9 
 
0.1 
1.1 
2.2 
 
0.2 
2.3 
8.3 
 
1.4 
 
0.9 
 
2.7 
 
1.2 
0.3 
0.5 
1.1 
0.9 
0.6-1.8 
1.6-12.7 
1.7-8.7 
 
0.0-0.9 
0.8-1.9 
1.8-5.6 
 
0.01-0.9 
0.6-9.3 
2.4-19.4 
 
1.0-3.9 
 
0.4-2.4 
 
1.3-5.6 
 
0.8-2.3 
0.07-1.2 
0.2-1.4 
0.4-3.2 
0.2-2.5 
0.33 
0.013 
0.001 
 
0.17 
0.61 
0.017 
 
0.12 
0.26 
0.001 
 
0.04 
 
0.88 
 
0.006 
 
0.10 
0.08 
0.18 
0.90 
0.67 
Meningoencephalomyelitis Unknown 
Aetiology (MUA) 
29 
Signalment (age, size) 
 
 
 
 
 
 
 
Onset (days to presentation) 
 
 
 
Deteriorating 
 
Pain  
 
Asymmetry 
 
Neuroanatomical localisation 
Smaller 
Medium size 
Larger 
 
Younger 
Middle aged 
Older 
 
Peracute 
Acute 
Chronic 
 
Deteriorating 
 
Painful 
 
Asymmetrical 
 
Multifocal 
C1-C5 
C6-T2 
T3-L3 
L4-S3 
1.4 
0.56 
0.4 
 
0.7 
0.8 
0.3 
 
0.6 
7.1 
1.6 
 
1.3 
 
2.3 
 
1.1 
 
38.7 
0.6 
0.2 
1.0 
0.9 
1.1-6.3 
0.2-1.8 
0.1-2.0 
 
0.5-1.3 
0.6-2.4 
0.04-1.8 
 
0.3-1.8 
1.2-21.8 
0.2-11.0 
 
0.4-3.7 
 
0.4-9.4 
 
0.4-3.7 
 
4.6-126.8 
0.04-10.8 
0.01-3.8 
0.06-17.1 
0.2-14.3 
0.11 
0.33 
0.27 
 
0.41 
0.18 
0.34 
 
0.41 
0.03 
0.62 
 
0.67 
 
0.23 
 
0.82 
 
0.01 
0.75 
0.32 
0.81 
0.83 
Acute Non-Compressive Nucleus 
Pulposus Extrusion (ANNPE) 
24 
Signalment (age, size) 
 
 
 
 
 
 
 
Smaller 
Medium size 
Larger 
 
Younger 
Middle aged 
Older 
 
0.6 
3.8 
2.0 
 
0.9 
0.8 
0.8 
 
0.3-1.1 
1.0-14.7 
0.9-6.5 
 
0.2-2.8 
0.1-3.7 
0.1-6.1 
 
0.19 
0.01 
0.03 
 
0.59 
0.57 
0.82 
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Onset (days to presentation) 
 
 
 
Deteriorating 
 
Pain  
 
Asymmetry 
 
Neuroanatomical localisation 
Peracute 
Acute 
Chronic 
 
Deteriorating 
 
Painful 
 
Asymmetrical 
 
Multifocal 
C1-C5 
C6-T2 
T3-L3 
L4-S3 
2.0 
0.5 
0.1 
 
0.4 
 
0.4 
 
2.2 
 
N/A 
1.4 
1.1 
2.1 
N/A 
1.1-3.6 
0.2-1.3 
0.01-0.6 
 
0.3-1.1 
 
0.2-1.1 
 
1.1-4.7 
 
N/A 
0.3-16.1 
0.3-23.1 
0.9-24.6 
N/A 
0.04 
0.16 
0.09 
 
0.04 
 
0.07 
 
0.04 
 
N/A 
0.61 
0.71 
0.12 
N/A 
Degenerative Lumbosacral Stenosis 
(DLSS) 
14 
Signalment (age, size) 
 
 
 
 
 
 
 
Onset (days to presentation) 
 
 
 
Deteriorating 
 
Pain  
 
Asymmetry 
 
Neuroanatomical localisation 
Smaller 
Medium size 
Larger 
 
Younger 
Middle aged 
Older 
 
Peracute 
Acute 
Chronic 
 
Deteriorating 
 
Painful 
 
Asymmetrical 
 
Multifocal 
C1-C5 
C6-T2 
T3-L3 
L4-S3 
0.3 
0.8 
12.3 
 
0.2 
1.1 
2.8 
 
0.9 
2.4 
4.6 
 
2.6 
 
1.8 
 
3.3 
 
0.2 
N/A 
N/A 
0.3 
3.9 
0.1-0.8 
0.5-2.3 
1.6-96.1 
 
0.1-1.8 
0.3-37.7 
0.06-128.3 
 
0.8-1.1 
0.6-11.4 
0.9-15.1 
 
0.5-11.8 
 
1.1-8.6 
 
0.6-18.2 
 
0.1-0.8 
N/A 
N/A 
0.03-0.28 
2.8-21.3 
0.10 
0.35 
0.02 
 
0.21 
0.87 
0.61 
 
0.79 
0.25 
0.10 
 
0.26 
 
0.44 
 
0.17 
 
0.11 
N/A 
N/A 
0.14 
0.08 
Cervical Spondylomyelopathy (CSM) 10 
Signalment (age, size) 
 
 
 
 
 
 
 
Onset (days to presentation) 
 
 
 
Deteriorating 
 
Pain  
 
Asymmetry 
 
Neuroanatomical localisation 
Smaller 
Medium size 
Larger 
 
Younger 
Middle aged 
Older 
 
Peracute 
Acute 
Chronic 
 
Deteriorating 
 
Painful 
 
Asymmetrical 
 
Multifocal 
C1-C5 
C6-T2 
T3-L3 
L4-S3 
0.1 
1.8 
6.7 
 
16.3 
3.2 
1.2 
 
0.4 
2.1 
10.4 
 
0.9 
 
2.9 
 
4.9 
 
N/A 
4.6 
5.1 
N/A 
N/A 
0.0-1.2 
1.0-16.3 
1.1-55.2 
 
3.6-36.1 
0.8-30.3 
0.3-6.1 
 
0.1-1.3 
0.2-21.6 
1.1-100.8 
 
0.3-3.4 
 
0.3-24.3 
 
0.9-26.2 
 
N/A 
3.2-16.1 
1.8-26.1 
N/A 
N/A 
0.34 
0.31 
0.04 
 
0.02 
0.16 
0.36 
 
0.31 
0.54 
0.04 
 
0.91 
 
0.32 
 
0.06 
 
N/A 
0.09 
0.13 
N/A 
N/A 
